From: [c--o--n] at [dsmnet.com] (Carl E. Olsen) Newsgroups: alt.hemp,alt.drugs,talk.politics.drugs Subject: NORML's new look Date: Sun, 4 Dec 1994 10:23:37 NORML's new look: Tie-dyes out, suits in By Dennis Cauchon USA TODAY In an effort to shed its image as a fringe group, the National Organization for the Reform of Marijuana Laws has recruited an all-star group of scientists -- including a Nobel Prize winner -- for its board. NORML hopes the move to the mainstream will restore the influence the group had in the 1970s. "This board will get people to take the issue seriously, which is our biggest problem," says Richard Cowan, NORML's national director. The new board was recruited only after a bitter fight in NORML that often pitted mainstream members against counterculture activists. "The people in suits have taken over. The tie-dyes aren't welcome anymore," complains dissident Jeanne Lange, who was forced off the board. "They're mainstreaming a counterculture group and that's a tragedy." On the new board: * Kary Mullis, who won the 1993 Nobel Prize in chemistry. * Harvard Medical School professor Lester Grinspoon, author of Marijuana: The Forbidden Medicine. * Louis Lasagna, dean of Sackler School of Biomedical Sciences at Tufts University and chairman of the National Academy of Sciences committee that studied marijuana. * Ann Druyan, secretary of the Federation of American Scientists and co-producer, with husband Carl Sagan, of the PBS series Cosmos. * Medical professor John Morgan, author of the drug-abuse section in the Merck Manual of Diagnosis and Therapy. New York University medical professor Gabriel Nahas, a NORML opponent, says the board has impressive names, but "none of these scientists have done any work on the clinical effect of marijuana." Says physician Eric Voth, another outspoken NORML critic: "These are prestigious individuals, but they are not experts on drug abuse or the drug issue." Mullis, for example, won the Nobel Prize for inventing a quick and accurate way to replicate DNA. His discovery -- called a PCR test -- will be used in the O.J. Simpson case. It also allows scientists to find genes that cause disease and trace human evolution. Cowan dismisses the criticism, saying several of the scientists have written extensively on marijuana. "It's irrelevant anyway," he says. "Were selling freedom, not marijuana. We're trying to stop 400,000 arrests each year, not tell people to smoke pot." Cowan, 54, a libertarian oil man from Texas, has reshaped NORML over the last two years. When he took over, NORML was down to one employee, heavily in debt and in trouble with the Internal Revenue Service. NORML now has eight employees. Its annual budget has doubled to $400,000 and paid membership has tripled to 6,000. A tax lawyer and accountant help with the books. But Cowan, a Yale-educated friend of conservative writer William Buckley, rubbed some members of the board the wrong way. They accused him of mismanagement in July and tried to take control of the group's daily finances. Cowan supporters prevailed. "Dick Cowan is the best thing to happen to NORML in a long time," says Grinspoon, the Harvard professor who led the effort to recruit the new board. "The idiots before him had nearly destroyed NORML." Grinspoon says the scientists were enthusiastic about joining a new NORML board. Drug war advocates "like to perpetuate the idea that being on the NORML board is something nasty, a mark of shame," Grinspoon says. "That's ridiculous. The group's reputation has sunk, but we're going to elevate, and picking these people for the board is a good start. USA TODAY, Friday, November 25, 1994, page 7A.